Adenosine dextran conjugates

Details Adenosine dextran conjugates Adenosine dextran conjugates

1994-03-21

1995-06-13

Robinson, Douglas W.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

514814, 536 2613, 536112, 544272, 544273, A61K 31715, A61K 3152, C07H 19167

Patent

active

054242975

ABSTRACT:
Covalent conjugates of water soluble dextrans and adenosine agonists or antagonists wherein the dextran is coupled through the C6 or C8 positions of the purine ring. These compounds activate or block adenosine A.sub.1 or A.sub.2 receptors are useful in treating hypertension.

REFERENCES:
Sigma Chemcial Catalog, 1990, Sigma Chemical Company, Inc., St. Louis, Mo.
Votruba et al. Collection Czechoslovak Chem. Commun. vol. 48, pp. 2549-2557, 1983.
Balcells et al. European Journal of Pharmacology, vol. 210, pp. 1-9, 1992.
Lippman, Richard D. J. Biochem. Biophys. Methods, vol. 6, pp. 81-87, 1982.
Clemo, Henry F. and Luiz Belardinelli. "Effect of Adenosine on Atrioventricular Conduction. II: Modulation of Atrioventricular Node Transmission by Adenosine in Hypoxic Isolated Guinea Pig Hearts", Circulation Research, vol. 59. No. 4, Oct. 1986, pp. 437-446.
Nees, S. et al. "The Coronary Endothelium: a Highly Active Metabolic Barrier for Adenosine", Basic Research in Cardiology, vol. 80, No. 5 (1985), pp. 314, 517-529.
Spielman, William S. "Antagonistic Effect of Theophylline on the Adenosine-Induced Derease in Renin Release", pp. F246-F251, 1984.
Schrader, Jurgen et al. "Evidence for a cell Surface Adenosine Receptor on Coronary Myocytes and Atrial Muscle Cells", Pflugers Arch. 369: European Journal of Physiology, (1977), pp. 251-257.
Armstrong, Kenneth J. et al. "Dextran-Linked Insulin: A soluble High Molecular Weight Derivative with Biological Activity In Vivo and In Vitro", Biochemical and Biophysical Research Communications, vol. 47, No. 2, (1972), pp. 354-360.
Olsson, Ray A. et al. "Evidence for an Adenosine Receptor on the Surface of Dog Coronary Myocytes", Circulation Research, vol. 39, No. 1, Jul. 1976. pp. 94--98.
Balcells, Eduardo et al. "Functional Role of Intravascular Coronary Endothelial Adenosine Receptors", European Journal of Pharmacology, 210 (1992), pp. 1-9.
Balcells, Eduardo et al. "Functional Role of Intravascular Coronary Endothelial Adenosine Receptors", European Journal of Pharmacology, 210 (1991), pp. 1-9.
Rubio, R. et al. "Adenosine Receptor Agonists and Antagonists II (8118-8122)", FASEB J., vol. 5, No. 6: A1769, Apr. 25, 1991, No. 8118.
Balcells, E. et al., Abstract of the 63rd Scientific Sessions, vol. 82:III-149, Nov. 15, 1990, No. 0590.
Bruns, R., Biochemical Pharmacology, vol. 30, pp. 325, Pergamon Press Ltd. 1981, "Adenosine Antagonism by Purines, Pteridines and Benzopteridines in Human Fibroblasts".
Jacobson, K. et al., Biochemical Pharmacology, vol. 36, No. 10, pp. 1697, 1987 "Molecular Probes for Extracellular Adenosine Receptors".
Jacobson, K. et al., J. Med. Chem., 32:1043, 1989, "Electrophilic Derivatives of Purines as Irreversible Inhibitors of A.sub.1 Adenosine Receptors".
Daly, J. et al., Biochemical Pharmacology, vol. 35, No. 35, pp. 2467, 1986, "Structure-Activity Relationships for N.sup.o -Substituted Adenosines at a Brain A.sub.1 -Adenosine Receptor with a Comparison to an A.sub.2 -Adenosine Receptor Regulating Coronary Blood Flow".
Daly, J. et al., J. Med. Chem., 28:487, 1984, "1,3-Dialkyl-8-(p-p-sulfophenyl)xanthines: Potent Water-Soluble Antagonists for A.sub.1 -and A.sub.2 -Adenosine Receptors".
Cristalli, G. et al., J. Med. Chem., 31:1179, 1988, "Adenosine Receptor Agonists: Synthesis and Biological Evaluation of 1-Deaza Analogues of Adenosine Derivatives".
Bridges et al., J. Med. Chem., 31:1282-1285, 1988, "N.sup.6 -[2-(3,5-Dimethoxyphenyl)-2-(2-methylphenyl)-ethyl]adenosine and Its Uronamide Derivatives, Novel Adenosine Agonists with both High Affinity and High Selectivity for the Adenosine A.sub.2 Receptor".
Jacobson, K. et al., fEBS Letters, 225:97, 1987, "Adenosine Analogs with Covalently Attached Lipids Have Enhanced Potency at A.sub.1 -Adenosine Receptors".
Stiles, G. et al., Molecular Pharmacology, 82:184, 1987, "A New High Affinity, Iodinated Adenosine Receptor Antagonist as a Radioligand/Photoaffinity Crosslinking Probe".
Jacobson, K. et al., Molecular Pharmacology, 29:126, 1985, "A Functionalized Congener Approach to Adenosine Receptor Antagonists: Amino Acid Conjugates of 1,3-Dipropylxanthine".
Olafsson, B. et al., Laboratory Investigation, vol. 76, No. 5, Nov. 1987, "Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: importance of the endothelium and the no-reflow phenomenon".
Babbit, D. et al., Circulation; 80:1388, 1989, "Intracoronary Adenosine Administered After Reperfusion Limits Vascular Injury After Prolonged Ischemia in the Canine Model".
Liu G. et al., Circulation; 84:350, 1991, "Protection Against Infarction Afforded by Preconditioning is Mediated by A.sub.1 Adenosine Receptors in Rabbit Heart".

Affiliated with

Also associated with

Rating

Adenosine dextran conjugates does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Adenosine dextran conjugates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adenosine dextran conjugates will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1309402